A new liver-targeted agonist of thyroid hormone receptor beta resmetirom in treating MASLD/MASH: From mechanism to therapy

Molecular Therapy 2026 Open access

Read full text

Authors: Monan Liu, Ye Ma, Wai San Cheang, Zhengding Su, Suowen Xu

DOI: 10.1016/j.ymthe.2026.04.011

Cited by: 5

References: 223

Fields of Study & Subjects

Liver Diseases and Immunity Thyroid Disorders and Treatments Drug-Induced Hepatotoxicity and Protection

References 223